A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Vaccine ChAdOx1 MERS in UK Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Middle East respiratory syndrome coronavirus vaccine - Vaccitech (Primary)
- Indications Middle East respiratory syndrome coronavirus
- Focus Adverse reactions
- 10 Apr 2018 Planned End Date changed from 1 Jan 2019 to 1 Mar 2019.
- 10 Apr 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Mar 2019.
- 10 Apr 2018 Status changed from not yet recruiting to recruiting.